Approval of Biogen’s Alzheimer’s drug aducanumab

Post Date:
July 2021

Nick Karachalias PhD of Osprey Health Consulting says that the FDA’s lowering of the regulatory bar in granting conditional approval to Alzheimer’s drug aducanumab comes with many and far-reaching  dangers – but also creates opportunity for the best prepared pharma […]

The Evolution of Scenario Planning and Simulation to Address Modern Market and Landscape Challenges

Post Date:
April 2019

Having worked in the field of future decision making and strategy for many years our team have increasingly recognised the shortcomings of the traditional approach to scenario planning and simulation.

Insight, market monitoring and assessing whether a brand plan is fit for purpose

Post Date:
December 2018

This article is the last in a series of three from Osprey Health Consulting. In this third article we will cover the importance of insight and measurement in brand planning and provide the brand planner with a checklist to assess whether their plan addresses the challenges of the modern pharmaceutical market.

Brand planning in complex and uncertain markets

Post Date:
November 2018

In our first article we addressed the modern challenges to strategic planning; the growing complexity and uncertainty that presents challenges to creating a comprehensive and coherent vision of the future.

Strategic planning in increasingly complex and uncertain markets, the David Cassidy dilemma

Post Date:
October 2018

This article is the first in a series of three from Osprey Health Consulting that address the contemporary challenges facing strategic brand planners dealing with increasingly complex and uncertain markets.